Active Violation Reports
All findings reflect publicly available Health Canada enforcement actions, regulatory warnings, and ICPS-assessed violations. No vendor has input on what is published here. Records are permanent.
| Operator | Category | ICPS Status | Reported | Source | Alert |
|---|---|---|---|---|---|
| Canlab Research Unauthorized injectable drug products sold online. Health Canada enforcement action initiated. Products include peptide injectables without DIN or NPN. |
Research Compounds | Critical | Aug 14, 2025 | Health Canada | Active |
| Prime Research Unauthorized injectable peptide drugs sold online. Health Canada seizure and enforcement notice issued. |
Research Compounds | Critical | Apr 14, 2025 | Health Canada | Active |
| Operator Under Review Pending Undeclared pharmaceutical ingredient identified in natural health product. Health Canada advisory issued. Product recalled. |
Natural Health Products | High Risk | 2025 | Health Canada | Active |
| Operator Under Review Pending Compounded semaglutide products sold without Health Canada authorization. Risk of dosing errors and contamination. |
Research Compounds | High Risk | 2025 | Health Canada | Active |
| Operator Under Review Pending Peptide products sold with COA referencing non-accredited laboratory. NPN not found on LNHPD database. |
Peptides | High Risk | 2025 | LNHPD | Monitoring |
| Operator Under Review Pending Product continued to be sold after NPN lapsed. No current licence on LNHPD. Label claims under assessment. |
Natural Health Products | Moderate | 2025 | LNHPD | Monitoring |
| Operator Under Review Pending ICPS-initiated review. COA provided by vendor does not disclose analytical method. Purity claim unverifiable. |
Peptides | Moderate | 2026 | ICPS Review | Monitoring |
Records marked "Pending" are under active source verification. Data updated as enforcement notices are confirmed. Submit a source